2054-6181

EMJ Diabetes

European Medical Group

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 136 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact136 DOIs
2

Add license metadata to 135 records

License metadata tells indexers and readers how each article may be reused.

High impact135 DOIs
3

Deposit reference lists for 41 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact41 DOIs

DOIs for this ISSN

Showing the top 5 of 135 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Psychological Aspects of Diabetes (10.33590/emjdiabet/20-00174)
ORCID License
72.36 27
2 Role of Probiotics in Diabetes: A Review of Their Rationale… (10.33590/emjdiabet/10310327)
ORCID License
63.94 18
3 Pathophysiology of Gestational Diabetes Mellitus (10.33590/emjdiabet/10313616)
References ORCID License
63.38 6
4 Multidisciplinary Approach to Management and Care of Patient… (10.33590/emjdiabet/10314374)
ORCID License
61.52 16
5 Detection and Early Lifestyle Intervention in Those at Risk… (10.33590/emjdiabet/10313999)
References ORCID License
52.42 4
6 Implication of the MAPK Signalling Pathway in the Pathogenes… (10.33590/emjdiabet/10311665)
ORCID License
52.07 10
7 Growth Hormone and Metabolic Homeostasis (10.33590/emjdiabet/10313977)
ORCID License
52.07 10
8 Evaluation of The Relationship Between Glycaemic Regulation… (10.33590/emjdiabet/10311581)
ORCID License
47.71 8
9 Comorbidity of Anxiety and Depression with Hypertension, Dia… (10.33590/emjdiabet/21-00189)
ORCID License
47.71 8
10 Membrane Flexibility and Cellular Energy Management in Type… (10.33590/emjdiabet/10313367)
References ORCID License
45.15 3
11 Efficacy of Wearable Devices to Measure and Promote Physical… (10.33590/emjdiabet/10312817)
ORCID License
38.91 5
12 Targeting Adipose Tissue Lipid Metabolism to Improve Glucose… (10.33590/emjdiabet/10311131)
References ORCID License
35.78 2
13 Diffusion Tensor Imaging Of the Brain in Type 1 Diabetes (10.33590/emjdiabet/10312425)
References ORCID License
35.78 2
14 Moderate Hypoxia Exposure: A Novel Strategy to Improve Gluco… (10.33590/emjdiabet/10310044)
ORCID License
34.95 4
15 Knowledge, Practices, and Risk of Diabetic Foot Syndrome Amo… (10.33590/emjdiabet/10310864)
ORCID License
34.95 4
16 Why Are Incretin-Based Therapies More Efficient in East Asia… (10.33590/emjdiabet/10312637)
ORCID License
34.95 4
17 Editor’s Pick: How Can We Develop More Effective Strategies… (10.33590/emjdiabet/10313184)
ORCID License
34.95 4
18 Gestational Diabetes: Comparison of Random and Fasting Plasm… (10.33590/emjdiabet/20-00119)
ORCID License
34.95 4
19 Fast Progression of Diabetic Retinopathy with SARS-CoV-2 Inf… (10.33590/emjdiabet/20-00254)
ORCID License
34.95 4
20 Chronic Complications of Diabetes (10.33590/emjdiabet/21-00180)
ORCID License
34.95 4
21 Kidney Disease: Improving Global Outcomes (KDIGO) New Guidel… (10.33590/emjdiabet/201014)
ORCID
31.38 17
22 Diabetic Ketoacidosis in Pregnancy: An Overview of Pathophys… (10.33590/emjdiabet/10194487)
ORCID License
30.10 3
23 Chrono-nutrition and its Association with Chronotype and Blo… (10.33590/emjdiabet/10300576)
ORCID License
30.10 3
24 The Concept of Early Vascular Ageing – An Update in 2015 (10.33590/emjdiabet/10312465)
ORCID License
30.10 3
25 Future Treatments of Diabetic Retinopathy: Pharmacotherapeut… (10.33590/emjdiabet/10313575)
ORCID License
30.10 3
26 Reproductive Dysfunctions in Males with Type 2 Diabetes Mell… (10.33590/emjdiabet/20-00171)
ORCID License
30.10 3
27 COVID-19: Is it time to revisit the research on calcium chan… (10.33590/emjdiabet/200608)
ORCID License
30.10 3
28 Socio-demographic Determinants of Attendance in Diabetes Edu… (10.33590/emjdiabet/21-00079)
ORCID License
30.10 3
29 Hyperkalaemic Paralysis by Addisonian Crisis: A Near Fatal A… (10.33590/emjdiabet/yote2844)
Abstract References ORCID License
30.10 1
30 Treatment Strategies for Chorioretinal Vascular Diseases: Ad… (10.33590/emjdiabet/10310409)
ORCID License
23.86 2
31 Treatment of Type 2 Diabetes with Biphasic Insulin Analogues (10.33590/emjdiabet/10310988)
ORCID License
23.86 2
32 Disparities in Diabetes Care (10.33590/emjdiabet/21-00194)
ORCID License
23.86 2
33 A Case of Mauriac Syndrome Caused by Social Inequities in He… (10.33590/emjdiabet/nogq9587)
ORCID License
23.86 2
34 Who Gets Diabetic Macular Oedema; When; and Why? Pathogenesi… (10.33590/emjdiabet/10311312)
References ORCID License
22.58 1
35 An Unexpected Post-ocrelizumab Improvement in Glycaemic Cont… (10.33590/emjdiabet/10089148)
ORCID License
15.05 1
36 Hidden Complication of Obesity and Diabetes: Is It Time to P… (10.33590/emjdiabet/10307262)
ORCID License
15.05 1
37 Home Diabetes Anti-Hyperglycaemic and Lipid Profile Regula… (10.33590/emjdiabet/10310563)
ORCID License
15.05 1
38 Family Models of Diabetes Self-Management Education: The Cur… (10.33590/emjdiabet/10310889)
ORCID License
15.05 1
39 Editor’s Pick: Addressing Hypertension in the Patient with T… (10.33590/emjdiabet/10312697)
ORCID License
15.05 1
40 Update on the Management of Diabetic Dyslipidaemia (10.33590/emjdiabet/10312768)
ORCID License
15.05 1
41 Low-Carbohydrate Diets and Glycaemic Control in Type 1 Diabe… (10.33590/emjdiabet/10313261)
ORCID License
15.05 1
42 Anti-Vascular Endothelial Growth Factor Therapy in Diabetic… (10.33590/emjdiabet/10313316)
ORCID License
15.05 1
43 Anti-Vascular Endothelial Growth Factor Therapy in Diabetic… (10.33590/emjdiabet/10314891)
ORCID License
15.05 1
44 Continuing Challenges in The Medical Management of Gestation… (10.33590/emjdiabet/20-00003)
ORCID License
15.05 1
45 Advanced Approaches in Immunotherapy for the Treatment of Ty… (10.33590/emjdiabet/20-00062)
ORCID License
15.05 1
46 Acute Worsening of Glycaemic Control in a Patient with Laten… (10.33590/emjdiabet/21-00263)
ORCID License
15.05 1
47 Next Step in Incretin-Based Therapy: From Single to Dual Ago… (10.33590/emjdiabet/22-00140)
ORCID License
15.05 1
48 The Potential Impact of Gestational Diabetes Mellitus on Lon… (10.33590/emjdiabet/gptz1914)
ORCID License
15.05 1
49 Treatment of Type 2 Diabetes: A Comprehensive Review of Rece… (10.33590/emjdiabet/rkyo7834)
ORCID License
15.05 1
50 Implications of Elevated Postprandial Glucose and Nutritiona… (10.33590//emjdiabet/10047523)
ORCID License
0.00 0